DVB,
There will not be an alteration of the molecule, IMO. There will be trials demonstrating efficacy in a host of indications, then labeling extensions.
Similar to what has happened with other immune modulating mAbs.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-